Register Now for DUKE DEBATES: Controversies in the Management of Patients with Hematologic Malignancies
March 1, 2018
The purpose of this conference is to provide education on the evolving and contemporary standards of care for the optimal treatments of patients with hematologic malignancies.
January 8, 2018
The Society for Immunotherapy of Cancer's (SITC) Advances in Cancer Immunotherapy™ session is an introductory, CME-, CNE-, and CPE-certified program specifically designed for the entire medical team involved in treating cancer patients. Presented by local, leading experts, this program will provide an understanding of basic cancer immunotherapy principles, current and emerging drugs, and the latest concepts in the clinical application and management of cancer patients.
September 27, 2017
Dr. Ivy Altomare discusses blood disorders and ITP on SiriusXM Doctor Radio.
August 25, 2017
FRMC is proud to receive the prestigious American Heart Association's Mission: Lifeline STEMI Receiving Center Gold Plus Award, the NSTEMI Receiving Center Bronze Award, and the Get-With-The-Guidelines Heart Failure Gold Plus Award. Also awarded was the American College of Cardiology's Platinum Award in ACTION Registry heart attack care. All awards are the highest level possible, showcasing FRMC's commitment to excellence in cardiac care for their patients.
August 23, 2017
LMC received the prestigious American College of Cardiology's Mission:Lifeline STEMI Receiving Center Gold Plus Award for the second year in a row. This award showcases LMC's commitment to excellence in heart attack patient care.
Dr Ivy Altomare Publishes Retrospective Study on Bleeding in Elderly Patients with Primary Immune Thrombocytopenia
August 11, 2017
Duke Cancer Network's Dr. Ivy Altomare studies elderly patients with primary immune thrombocytopenia.
August 10, 2017
Duke Cancer Network's Dr. Ivy Altomare receives credit as a study author on "Out-of-Pocket Costs, Financial Distress, and Underinsurance in Cancer Care," a Duke University study on the high financial burden cancer patients face.
July 24, 2017
Dr Linda Sutton discusses the role of CDK4/CDK5 inhibitors for the treatment of breast cancer patients at the 42nd annual meeting of the Oncology Nursing Society.
July 21, 2017
Luncheon in Lumberton honors the staff, including Dr Marvaretta Stevenson, at Southeastern Health's Gibson Cancer Center and the family of M. Carr and Alice Gibson.
May 15, 2017
Dr. Linda Sutton and Dr. Donette Vicente discuss Nourishing Your Emotional Health during Breast Cancer.